Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Washington, District of Columbia 20037


Purpose:

The study seeks to identify genomic markers associated with aspirin resistance.


Criteria:

Inclusion Criteria: - Volunteers 40 to 80 years old willing to sign consent and take 81 mg of aspirin for 7 - 10 days and return for laboratory testing. Exclusion Criteria: - Patient requiring more than 81 mg aspirin daily - Known GI bleeding attributed to ASA - Active peptic ulcer disease or history within the last year - Known aspirin allergy - Current use of: - warfarin, - heparin, - NSAIDs (except aspirin), - clopidogrel, - dipyridamole, - fish-oil/omega 3 supplements, - Women of childbearing potential who are pregnant, planning to become pregnant or nursing.


NCT ID:

NCT01361620


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Washington, District of Columbia 20037
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.